NXTS Nexentis Technologies Inc.

CIK 0001789192 50 ready 8-Ks latest May 27, 2026, 4:05 PM ET RSS · JSON

Activity: NORMAL 1 filings / 30d vs 1 baseline

Ready 8-Ks 50

Latest filing August 6, 2026, 4:06 PM ET

Top materiality 0.75

Event mix other_material ×29 · m_and_a ×10 · debt ×5

Sentiment 8 pos · 4 neg · 38 neu

Executive change recent →

SHENANIGAN SCORE 3 / 7 see the board

Recent 8-K filings for NXTS

Highest-materiality recent filing

N2OFF to transfer 98% stake in Save Foods to Voice Assist for 19.99% of Voice Assist stock

January 13, 2026, 6:59 PM ET M&A materiality 0.75 neutral item 1.01 item 3.02 item 9.01 ◈ Material Agreements ×2

N2OFF to transfer 98% stake in Save Foods to Voice Assist; consideration: 60.2M Voice Assist shares (19.99% fully diluted).
Closing expected within 90 days, subject to due diligence, tax opinion, and consents.

Read filing →

May 27, 2026, 4:05 PM ET debt materiality 0.65 neutral item 1.01 item 2.03 item 9.01 ◈ Material Agreements

Nexentis increases L.I.A. Pure Capital credit facility to EUR 10M, issues 1.85M share warrants at $1.00

Amended facility increases borrowing capacity from EUR 6M to EUR 10M, interest unchanged at 7% per annum.
March 17, 2026, 7:59 PM ET M&A materiality 0.70 neutral item 2.01 item 9.01 ◈ M&A Transactions

Nexentis closes transfer of 98% stake in Save Foods to Voice Assist for 19.99% equity

Closed on March 15, 2026; transferred all Save Foods shares owned (~98% of outstanding).
January 13, 2026, 6:59 PM ET M&A materiality 0.75 neutral item 1.01 item 3.02 item 9.01 ◈ Material Agreements ×2

N2OFF to transfer 98% stake in Save Foods to Voice Assist for 19.99% of Voice Assist stock

N2OFF to transfer 98% stake in Save Foods to Voice Assist; consideration: 60.2M Voice Assist shares (19.99% fully diluted).
November 12, 2025, 6:59 PM ET M&A materiality 0.70 negative item 8.01 item 9.01

N2OFF files MitoCareX audited financials; target had $886K net loss, going concern doubt in 2024

MitoCareX net loss for 2024 was $886K, accumulated deficit $1,760K; cash used in operations $797K.
October 23, 2025, 7:59 PM ET M&A materiality 0.60 neutral item 2.01 item 3.02 item 8.01 item 9.01 ◈ M&A Transactions

N2OFF closes acquisition of MitoCareX, issuing stock and $700K cash for 100% of biotech

Acquired 100% of MitoCareX, a drug discovery company targeting resistant cancers including pancreatic and non-small cell lung cancer.
September 25, 2025, 7:59 PM ET M&A materiality 0.70 neutral item 5.07 item 8.01 item 9.01

N2OFF shareholders approve acquisition of MitoCareX Bio; closing targeted by early Oct 2025

Stockholders voted 11.7M for, 197K against to approve the MitoCareX acquisition; reverse split and warrant share proposals also passed.
September 18, 2025, 7:59 PM ET other materiality 0.60 neutral item 8.01 item 9.01

N2OFF announces 1-for-35 reverse stock split effective Sept 22, 2025

Reverse stock split ratio 1-for-35, effective for Nasdaq on September 22, 2025.
September 9, 2025, 7:59 PM ET other material materiality 0.60 neutral item 1.01 item 3.03 item 5.03 item 9.01 ◈ Governance Changes

N2OFF effects 1-for-35 reverse stock split; adds €600K loan for battery study

Reverse stock split at 1-for-35 ratio, effective September 3, 2025; CUSIP changes.
August 14, 2025, 7:59 PM ET debt materiality 0.60 neutral item 2.03 item 1.01 item 3.02 item 9.01 ◈ Debt Financings

N2OFF draws $1.5M first tranche of $3M advance; issues 8% promissory note due 2026

Received $1.5M on August 12, 2025 from YA II PN as first part of $3M advance under amended Purchase Agreement.
July 28, 2025, 7:59 PM ET other material materiality 0.60 neutral item 3.02 item 1.01 item 9.01

N2OFF amends purchase agreement with YA II PN; issues 574,325 commitment shares

Amends May 12 Purchase Agreement with YA II PN; extends payment terms on $3M promissory notes.
July 24, 2025, 7:59 PM ET M&A materiality 0.60 neutral item 1.01 item 9.01

N2OFF amends MitoCareX acquisition: extends closing deadline, updates share counts and consideration caps

Outside Date extended by 90 days to 270 days from original agreement date (Feb 25, 2025).
May 13, 2025, 7:59 PM ET debt materiality 0.70 neutral item 2.03 item 1.01 item 3.02 item 9.01 ◈ Debt Financings

N2OFF secures up to $3M debt facility via Purchase Agreement with YA II PN

Up to $3M in two tranches: $1.5M after SEC filing, $1.5M after effectiveness.
April 10, 2025, 7:59 PM ET other material materiality 0.65 negative item 9.01

N2OFF sells 100% stake in NTWO OFF Ltd. for 15,000 NIS (~$4,000)

Sold 4,200,000 shares of NTWO (100% ownership) to Yaaran Investments for 15,000 NIS.
February 28, 2025, 6:59 PM ET M&A materiality 0.60 neutral item 1.01

N2OFF signs shareholders agreement to acquire 70% of SB Impact 4; to lend €2.3M for Sicily battery projects

N2OFF will purchase 70% of SBI4 shares from Solterra Brand Services Italy on final closing date.
February 26, 2025, 6:59 PM ET M&A materiality 0.75 positive item 1.01 item 7.01 item 9.01

N2OFF signs definitive agreement to acquire MitoCareX Bio in stock-cash deal

N2OFF will pay $700,000 cash to SciSparc for 4,961 shares and issue common stock totaling 40% of fully diluted capital to all sellers.
February 7, 2025, 6:59 PM ET other material materiality 0.75 positive item 8.01

N2OFF regains Nasdaq minimum bid price compliance; delisting risk removed

Nasdaq notified N2OFF on Feb 6, 2025 of compliance with $1.00 minimum bid price for 10 consecutive business days (Jan 23 - Feb 5).
January 6, 2025, 6:59 PM ET other material materiality 0.60 neutral item 3.02

N2OFF closes $1.5M private placement; issues shares and warrants

Issued 1,704,116 common shares, pre-funded warrants for 4,545,884 shares, and warrants for 9,375,000 shares on Jan 2, 2025.
December 10, 2024, 6:59 PM ET M&A materiality 0.70 neutral item 1.01 item 2.01 item 3.02

N2OFF raises $1.5M in private placement; acquires 65% of Plantify via debt settlement

Gross proceeds of ~$1.5M from 6.25M units at $0.24/unit; each unit includes common stock and warrants.
November 18, 2024, 6:59 PM ET other material materiality 0.65 neutral item 1.01 item 9.01

N2OFF settles CDN$2.05M debt with Plantify, to hold 65.4% of its common shares

Debt of CDN$2,052,879.39 settled via 2,420,848 Plantify shares at CDN$0.848 per share.
October 2, 2024, 7:59 PM ET other material materiality 0.75 positive item 2.03 item 1.01 item 3.02 item 7.01 item 9.01

N2OFF enters €6M credit facility, pursues spin-off and drug discovery acquisition

€6M non-recourse credit facility at 7% interest; warrant for 1.85M shares at $1.00 exercise price.
July 31, 2024, 7:59 PM ET other material materiality 0.60 neutral item 2.03 item 1.01 item 7.01 item 9.01

N2OFF commits up to €1.56M for 50% profit rights in 111 MW German solar project

N2OFF and private investors loan €2.08M (N2OFF share €1.56M) to Solterra for 111 MWp Melz solar project; 7% interest, 5-year maturity.
July 9, 2024, 7:59 PM ET regulatory materiality 0.70 negative item 3.01

N2OFF receives Nasdaq bid price deficiency notice; 180-day cure period

Nasdaq notified N2OFF that its stock (NITO) closed below $1.00 for 30 consecutive business days, violating Listing Rule 5450(a)(1).
April 16, 2024, 7:59 PM ET debt materiality 0.65 neutral item 1.01 item 2.03 item 3.02 item 9.01 ◈ Debt Financings◈ Material Agreements

N2OFF issues $1.5M promissory note to YA II PN, net $1.455M after 3% OID

Sold $1,500,000 note to YA II PN, Ltd.; proceeds $1,455,000 (3% original issue discount).